Despite this, oxidative drugs and G6PD deficiency screenings are not part of the national policy for the treatment of Plasmodium falciparum and Plasmodium vivax infections in Eritrea. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.